Navigation Links
Nile Therapeutics Reports 2010 Second Quarter Financial Results
Date:8/16/2010

g its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide. More information on Nile can be found at http://www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding the timing, progress and anticipated results of the clinical development, regulatory processes, clinical trial timelines, expected patient enrollment, anticipated benefits of CD-NP, Nile's strategy, future operations, outlook, milestones, the timing and success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that Nile makes include Nile's need to raise additional capital to fund its product development programs to completion, Nile's reliance on third-party researchers to develop its product candidates, and its lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in greater detail in the reports Nile files with Securities and Exchange Commission, including those described under the caption "Risk Factors" in Item 1A of its Annual Report on Form 10-K fo
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 Touro College has announced ... CanniCare,s application for one of five media marijuana licenses to ... Dept. of Health (DOH).  If CanniCare ... medicinal cannabis.  "Our college is supportive of ... president of the Touro College System. "There is still a ...
(Date:7/29/2015)... 29, 2015  Cepheid (Nasdaq: CPHD ) ... to Xpert® Carba-R, with the addition of two ... on-demand, molecular test also detects and differentiates among ... namely KPC, NDM, VIM, IMP-1 and OXA-48. ... or Superbugs, are a growing and expensive challenge ...
(Date:7/29/2015)... July 29, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... developing innovative therapeutics primarily in the areas of dermatology ... results for the second quarter ended June 30, 2015 ... the U.S. financial markets.  A live ... webcast link is available under the "Investors" section of ...
Breaking Medicine Technology:Touro College Announces Support for CanniCare's Medical Cannabis License Application 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 2RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 3
(Date:7/29/2015)... Madison, Wis. (PRWEB) , ... July 29, 2015 ... ... enrolled its first two patients in a Clinical Performance Study for the Invisiport ... includes 4.4 and 6 French catheter options, offers a less invasive, patient-friendly alternative ...
(Date:7/29/2015)... , ... July 29, 2015 , ... TransFlip is an ... as drag & drop presets for FCPX, these transitions are easy to apply and ... versatility to each transition. With over 60 preset styles, kinetic flipping panel animations are ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* ... research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the ...
(Date:7/29/2015)... Scottsdale, Arizona (PRWEB) , ... July 29, 2015 , ... ... residential dorms. The project, which will by the end will cost the 501(c) organization ... compliance of Arizona’s recent anti-ligature requirements. , “We took it down to the ...
(Date:7/29/2015)... ... ... The Woodlands and Spring Fit Body Boot Camps have implemented an engaging an interactive ... new system will track each time a client uses social media to Check In ... camps will donate 20 cents to a selected charity. , Fit Body Boot Camp ...
Breaking Medicine News(10 mins):Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... , Sebelius Releases New Nationwide Emergency Department ... , ROCKVILLE, Md., July 15 Health and Human ... Emergency Department Sample -- the largest, all-payer emergency department database in ... to help public health experts, policymakers, health care administrators, researchers, journalists ...
... , SACRAMENTO, Calif., July 15 For the ... drop was 9.1 percent, from 1,132 in 2007 to 1,029 in 2008, ... The 2008 figure marks a total decrease of nearly 21 percent ... , Alcohol impaired deaths make up the largest category of ...
... , , Measure ... , , SILVER SPRING, Md., July 15 ... Choices Act," introduced yesterday in the House of Representatives. In particular, ... care option as a key component in reforming our broken health care ...
... , PRINCETON, N.J., July 15 Diabetes ... use the insulin in their pump for up to six ... of a labeling change, diabetes care company Novo Nordisk announced ... in the pump reservoir for two days. This makes NovoLog((R)) ...
... could improve cognition, vaccine might fight ,tangles, of disease ... show promise against two different types of brain abnormalities, ... progression of Alzheimer,s disease. , A drug called Dimebon ... humans but, new research reveals, it actually increases ...
... SHENZHEN, China, July 15 /PRNewswire-FirstCall/ - Hard to Treat ... company is now preparing for the tender business of ... specifications and details can be viewed by visiting this ... the second completed batch exported to Indonesia this year ...
Cached Medicine News:Health News:New Data Say Uninsured Account for Nearly One-Fifth of Emergency Room Visits 2Health News:New Data Say Uninsured Account for Nearly One-Fifth of Emergency Room Visits 3Health News:DUI Deaths Down 9 Percent in California 2Health News:United American Nurses Hails House Health Care Reform Bill 2Health News:FDA Approves NovoLog(R) Labeling Update 2Health News:FDA Approves NovoLog(R) Labeling Update 3Health News:FDA Approves NovoLog(R) Labeling Update 4Health News:New Treatments for Alzheimer's on the Horizon 2Health News:New Treatments for Alzheimer's on the Horizon 3Health News:Hard To Treat Diseases (HTDS.PK) Tender Order To Indonesia 2
Inquire...
... Aerosol barrier tips eliminate false ... Scientifically designed and tested, Promega Barrier ... working with amplified nucleic acids (PCR(a)), ... samples, forensic and serological specimens. , ...
... ideal for PCR and other ... work where aerosol contamination might ... pipetting DNA/RNA solutions, infectious materials, ... applications requiring absolute sterility, they ...
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
Medicine Products: